Glutamate dehydrogenase

Glutamate dehydrogenase
Name	Glutamate dehydrogenase
EC number	1.4.1.2-1.4.1.4
CAS number	9001-46-1

Glutamate dehydrogenase. This enzyme is a central catalyst in nitrogen metabolism, primarily facilitating the reversible oxidative deamination of L-glutamate to α-ketoglutarate and ammonia. It serves as a critical link between carbohydrate metabolism and amino acid metabolism, utilizing cofactors such as NAD+ or NADP+. Found across all domains of life, from Archaea to Homo sapiens, its activity is pivotal in processes ranging from ammonia detoxification in the liver to neurotransmitter synthesis in the brain.

Function and reaction mechanism

The primary function of this enzyme is to catalyze the reversible interconversion of L-glutamate, water, and a nicotinamide cofactor into α-ketoglutarate, ammonia, and the reduced cofactor. This reaction positions it at a major metabolic crossroads, directly connecting the citric acid cycle with pathways for amino acid biosynthesis and catabolism. The mechanism involves the formation of a Schiff base intermediate between the substrate and a conserved lysine residue within the active site. Studies using X-ray crystallography and nuclear magnetic resonance have detailed this ping-pong mechanism, which is influenced by the allosteric regulation of various metabolites. In many organisms, the reaction favors ammonia production, playing a key role in nitrogen excretion.

Structure and isoforms

The enzyme typically assembles as a hexamer of identical subunits, each with a molecular weight of approximately 55 kilodaltons, forming a complex three-dimensional structure with profound quaternary structure implications. In mammals, two distinct isoforms are encoded by separate nuclear genes: the widely expressed GLUD1 and the neuroendocrine-specific GLUD2, the latter thought to have arisen via retrotransposition from GLUD1. The archaeal versions, such as those from Pyrococcus furiosus, are often thermostable and have provided high-resolution structural models through work at institutions like the European Synchrotron Radiation Facility. Each subunit contains a characteristic nucleotide-binding domain for NAD(P)+ and a substrate-binding glutamate dehydrogenase domain.

Regulation and kinetics

Activity is tightly controlled through a sophisticated network of allosteric effectors and post-translational modification. Key inhibitors include GTP and Palmitoyl-CoA, while ADP and Leucine act as potent activators, allowing the enzyme to respond to cellular energy charge. This regulation is exemplified in the liver, where high ATP levels signal sufficient energy and suppress activity. The kinetics often deviate from simple Michaelis-Menten kinetics, showing cooperativity influenced by the allosteric site occupancy. Research from Harvard Medical School and the Max Planck Institute has elucidated how phosphorylation by Protein kinase A can further modulate its function in certain tissues.

Physiological roles

Its physiological impact is vast, with critical functions in hepatic gluconeogenesis by providing α-ketoglutarate for the citric acid cycle. In the central nervous system, it is involved in the glutamate-glutamine cycle, regulating the levels of the excitatory neurotransmitter glutamate in synapses between neurons and astrocytes. Within the pancreatic islets, particularly in beta cells, it influences insulin secretion by modulating glutaminolysis. The enzyme is also essential for ammonia assimilation in plants and microorganisms, serving as a primary entry point for inorganic nitrogen into organic compounds.

Clinical significance

Dysregulation is implicated in several human pathologies. Hyperactivity is associated with congenital hyperinsulinism, as seen in patients with mutations reported in studies from Johns Hopkins Hospital. Conversely, a relative deficit in brain activity has been hypothesized to contribute to excitotoxicity in neurodegenerative diseases such as Alzheimer's disease and Huntington's disease. Autoantibodies against the enzyme are a serological marker for Autoimmune hepatitis, aiding in diagnosis alongside tests from the Mayo Clinic. Furthermore, its role in ammonia metabolism links it to the pathophysiology of hepatic encephalopathy and Reye syndrome.

Evolution and distribution

The enzyme is ancient, with homologous sequences identified in Bacteria, Archaea, and Eukarya, suggesting its presence in the last universal common ancestor. Its gene structure and regulatory mechanisms have diversified significantly; for instance, the GLUD2 isoform in primates evolved new regulatory properties adapted for the brain. The enzyme's distribution is ubiquitous but varies in form; some fungi and green algae possess NADP+-specific versions, while animal enzymes can use both NAD+ and NADP+. Research led by teams at MIT and the Pasteur Institute has used comparative genomics to trace the evolutionary adaptations of its allosteric regulation sites across different kingdoms (biology).

Category:Enzymes Category:Metabolism